Effect of a combined oral contraceptive containing 20 μg ethinyl estradiol and 75 μg gestodene on hemostatic parameters

References

• Inman W MW, Vessey M P, Westerholm B, Engelund A. Thromboembolic disease and steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; 2: 203–209
   PubMed Web of Science ®Google Scholar
• Kay C R. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Clin Obstet Gynaecol 1984; 11: 759–786
   PubMedGoogle Scholar
• Meade T W, Greenberg G, Thompson S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50 and 30 μg oestrogen preparations. Br Med J 1980; 280: 1157–1161
   PubMed Web of Science ®Google Scholar
• Vessey M P, Mann J I, Meade T W. Thrombosis and oral contraception. Br J Hosp Med 1981; 25: 205–206
   PubMedGoogle Scholar
• Suissa S, Spitzer W O, Rainville B, Cusson J, Lewis M, Heinemann L. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod 2000; 15: 817–821
   PubMed Web of Science ®Google Scholar
• Norris L A, Bonnar J. Haemostatic changes and the oral contraceptive pill. Baillieres Clin Obstet Gynaecol 1997; 11: 545–564
   PubMed Web of Science ®Google Scholar
• Conard J. Biological coagulation findings in third-generation oral contraceptives. Hum Reprod Update 1999; 5: 672–680
   PubMed Web of Science ®Google Scholar
• Prasad R N, Koh S C, Viegas O A, Ratnam S S. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel. Clin Appl Thromb Hemost 1999; 5: 60–70
   PubMed Web of Science ®Google Scholar
• Jung-Hoffmann C, Kuhl H. Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives. Contraception 1989; 40: 299–312
   PubMed Web of Science ®Google Scholar
• Van der Mooren M J, Klipping C, van Aken B, Helmerhorst E, Spielmann D, Kluft C. A comparative study of the effects of gestodene 60 μg/ethinylestradiol 15 μg and desogestrel 150 μg/ethinylestradiol 20 μg on hemostatic balance, blood lipid levels and carbohydrate metabolism. Eur J Contracept Reprod Health Care 1999; 4(Suppl 2)27–35
   PubMed Web of Science ®Google Scholar
• Schindler A E. Differential effects of progestins on hemostasis. Maturitas 2003; 46(Suppl 1)S31–S37
   PubMed Web of Science ®Google Scholar
• Petersen K R, Sidelman J, Skouby S O, Jespersen J. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Am J Obstet Gynecol 1993; 168: 32–38
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Ricci C, Fioretti P. Hemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives. Contraception 1994; 49: 579–592
   PubMed Web of Science ®Google Scholar
• Winkler U H, Schindler A E, Endrikat J, Dusterberg B. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol. Contraception 1996; 53: 75–84
   PubMed Web of Science ®Google Scholar
• Endrikat J, Klipping C, Gerlinger C, Ruebig A, Schmidt W, Holler T, Dusterberg B. A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids, and carbohydrate metabolism. Contraception 2001; 64: 235–241
   PubMed Web of Science ®Google Scholar
• The Oral Contraceptive and Hemostasis Study Group. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study. Contraception 2003; 67: 173–185
   PubMed Web of Science ®Google Scholar
• Ferreira A C, Montes M B, Franceschini S A, Toloi M R. Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women. Contraception 2001; 64: 353–356
   PubMed Web of Science ®Google Scholar
• World Health Organization, Reproductive Health and Research. Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use2nd ed. World Health Organization, Geneva 2000
   Google Scholar
• Odegard O R, Lie M, Abildgarrd U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 1975; 6: 287–294
   PubMed Web of Science ®Google Scholar
• Jespersen J. Pathophysiology and clinical aspects of fibrionolysis and inhibition of coagulation. Dan Med Bull 1988; 35: 1–25
   PubMedGoogle Scholar
• Jespersen J, Petersen K R, Skouby I SO. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 1990; 163: 396–403
   PubMed Web of Science ®Google Scholar
• Speroff L, DeCherney A. Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins. Obstet Gynecol 1993; 81: 1034–1047
   PubMed Web of Science ®Google Scholar
• Realini J P, Goldzieher J W. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol 1985; 152: 729–798
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582–1587
   PubMed Web of Science ®Google Scholar
• Fruzzetti F. Hemostatic effects of smoking and oral contraceptive use. Am J Obstet Gynecol 1999; 180: S369–S374
   Web of Science ®Google Scholar
• Petersen K R. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Dan Med Bull 2002; 49: 43–60
   PubMed Web of Science ®Google Scholar
• Omsjo I H, Oian P, Maltauu J M, Osterud B. Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation in fibrinolysis. Acta Obstet Gynecol Scand 1989; 68: 27–30
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Kitchens C S, Khan F Y. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: controlled comparative 12-month clinical trial. Am J Obstet Gynecol 1992; 167: 255–261
   Web of Science ®Google Scholar
• Fruzzetti F, Ricci C, Nicoletti I, Fioretti P. Clinical and metabolic effects of a triphasic pill containing gestodene. Contraception 1992; 46: 335–347
   PubMed Web of Science ®Google Scholar
• Siegbahn A, Ruusuvaara L. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost 1988; 60: 361–364
   PubMed Web of Science ®Google Scholar
• Abbate R, Pinto S, Rostagno C, Bruni V, Rosati D, Mariani G. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis. Am J Obstet Gynecol 1990; 163: 424–429
   PubMed Web of Science ®Google Scholar
• Alving B M, Comp P C. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol 1992; 167: 1184–1191
   PubMed Web of Science ®Google Scholar
• Smirova S, Chochola M, Varejka P, Aschermann M. Thromboembolic complications in the use of oral estrogen–gestagen contraceptives. Vnitr Lek 2001; 47: 460–464
   PubMedGoogle Scholar
• Girolami A, Spiezia L, Rossi F, Zanon E. Oral contraceptives and venous thromboembolism: which are the safest preparations available?. Clin Appl Thromb Hemost 2002; 8: 157–162
   PubMed Web of Science ®Google Scholar
• Skouby S O, Jespersen J, Petersen K P. Metabolic effects of oral contraceptives. Adv Contracept 1993; 9(Suppl 1)49–58
   PubMedGoogle Scholar
• Schindler A E. Differential effects of progestins on hemostasis. Maturitas 2003; 46(Suppl 1)S31–S37
   PubMed Web of Science ®Google Scholar
• Shoupe D. New progestins – clinical experiences: gestodene. Am J Obstet Gynecol 1994; 170: 1562–1568
   PubMed Web of Science ®Google Scholar